DHR Market Analysis
Wall Street coverage
third-party contextWall Street coverage
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
News & Sentiment
28 articles · sorted by dateVia 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Fundamentals
Updated daily after market closeValuation
- Forward P/E
- 25.06
- PEG ratio
- 1.39
- P/B
- 2.85
- P/S (TTM)
- 5.79
- EV/EBITDA
- 22.72
Profitability & growth
- ROE (TTM)
- 7.6%
- Operating margin
- 19.8%
- Revenue growth YoY
- 5.5%
- Dividend yield
- 0.7%
- Beta
- 0.80
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About Danaher Corporation
Company profileDanaher Corporation is an American globally diversified conglomerate with its headquarters in Washington, D.C.. The company designs, manufactures, and markets professional, medical, industrial, and commercial products and services. The company's 3 platforms are Life Sciences, Diagnostics, and Environmental & Applied Solutions.
Classification
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Exchange
- NYSE
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 2200 PENNSYLVANIA AVENUE N.W., WASHINGTON, DC
- Fiscal year end
- December
- Latest quarter
- Jun 30, 2026
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
